ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CDNA vs ACHC // GROSS PROFIT MARGIN

CareDx Inc. (NASDAQ) VS. Acadia Healthcare Company Inc. (NASDAQ) • 15-METRIC TALLY: CDNA 9 — ACHC 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CDNA VS. ACHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CDNA ACHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -8.20% -24.80% +16.60 CDNA /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 0.67% -16.04% +16.71 CDNA /fcf-yield <GO>
Operating Margin -8.10% -40.60% +32.50 CDNA /operating-margins <GO>
Net Profit Margin -5.60% -33.30% +27.70 CDNA /net-margins <GO>
Revenue Growth (YoY) 13.80% 5.00% +8.80 CDNA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 19.22 0.45 +18.77 CDNA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 5/9 +2.00 CDNA /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 67.4 50.9 +16.50 CDNA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.06 1.07 -0.01 ACHC /macro-sensitivity <GO>
Forward P/E Multiple 21.0x 21.0x 0.00 TIE /forward-pe <GO>
Enterprise Scale & Market Cap $4.59B $2.79B $1.80B CDNA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CDNA REV ACHC REV CDNA GROSS % ACHC GROSS % CDNA FCF ACHC FCF
FY 2025 $379.8M $3.31B — — $24.9M -$439.9M
FY 2024 $333.8M $3.15B — — $23.0M -$560.7M
FY 2023 $280.3M $2.93B — — -$31.0M $330.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CDNA // BETA 1.06
ACHC // BETA 1.07